The global FemTech industry continues to make waves in 2025, with exciting developments across menstrual health, fertility tech, digital contraception, and AI-powered diagnostic tools. This week’s highlights include major startup funding rounds, product launches, and strategic growth announcements—all aimed at improving women’s health through technology.
Funding Highlights in FemTech
- Joii (Ireland)
- Raised: €2.4 million seed funding
- Focus: Digital menstrual health platform using AI to track and manage cycle irregularities
- Plans: Expand across the EU and integrate predictive analytics for hormonal health.
- Hera Biotech (USA)
- Acquisition: Completed the acquisition of HeraFem, a point-of-care diagnostic solution for cervical and uterine health.
- Goal: Expand capabilities in non-invasive diagnostic testing for reproductive disorders like endometriosis and PCOS.
- Maya Health (India)
- Secured: Strategic pre-Series A round (undisclosed amount)
- Offering: A multilingual telehealth platform tailored for peri-menopausal and rural women, addressing access barriers in underserved regions.
Product Launches & Innovations
- Contraceptive App Upgrade: CycleIQ launched an AI-enhanced version of its popular digital birth control app, now offering real-time hormone-level prediction through wearables integration.
- Menopause Tech Expands: PauseWellness, known for its menopause relief supplements, is entering teleconsultation services with certified gynecologists and hormone therapy advisors.
FemTech Market Trends & Insights
- According to Frost & Sullivan, the global FemTech market is projected to reach $75 billion by 2027, growing from $40B in 2020.
- Top growth drivers include:
- Increased VC investment in women’s health
- Rising awareness around menstrual equity and reproductive autonomy
- Improved data analytics for personalized care
Despite the growth, the industry continues to face challenges such as:
- Data privacy concerns in menstrual tracking apps
- Underrepresentation in clinical trials
- Need for insurance coverage on femtech products and services
Mergers, Partnerships & Advocacy
- The FemTech Lab Accelerator (UK) announced a global collaboration with Women’s Health Innovation Series to accelerate time-to-market for startups focused on vaginal health, menopause, and mental well-being.
- Advocacy groups in the U.S. are lobbying for FDA fast-track status for digital therapeutics focused on endometriosis and postpartum depression.
Key Takeaways:
- FemTech startups globally are raising millions to address menstrual health, fertility, menopause, and digital diagnostics.
- Innovation continues in AI-based health tracking, telehealth for underserved women, and personalized hormone care.
- Industry growth is strong but must address privacy, access, and inclusion gaps to reach its full potential.
Source: FemTech Insider – What’s New in FemTech This Week? (June 19, 2025)
